References
1
Nolan CP, DeAngelis LM. Neurologic complications of chemotherapy and radiation therapy. Continuum (Minneap Minn) 2015; 21: 429-51.
2
Yağmurlu B, Akyürek S, Fitoz S, Demirkazik A. MRI of non-neoplastic cranial complications of malignant disorders. Diagn Interv Radiol 2008; 14: 61-8.
3
Taillibert S, Le Rhun E, Chamberlain MC. Chemotherapy-related neurotoxicity. Curr Neurol Neurosci Rep 2016; 16: 81.
4
Rossi Espagnet MC, Pasquini L, Napolitano A, Cacchione A, Mastronuzzi A, Caruso R, et al. Magnetic resonance imaging patterns of treatment-related toxicity in the pediatric brain: an update and review of the literature. Pediatr Radiol 2017; 47: 633-48.
5
Dietrich J. Neurotoxicity of Cancer Therapies. Continuum (Minneap Minn) 2020; 26: 1646-72.
6
Valle DA, Kakehasi FM, Melo RM, Siqueira CM, Soares TF, Rodrigues KE. Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report. Rev Bras Hematol Hemoter 2016; 38: 364-7.
7
Ozer M, Dumas B, Horta L, Sadrzadeh H. 5-Fluorouracil associated neurovascular toxicities. Curr Probl Cancer 2021; 45: 100746.
8
Vaswani AK, Nizamani WM, Ali M, Aneel G, Shahani BK, Hussain S. Diagnostic accuracy of contrast-enhanced FLAIR magnetic resonance imaging in diagnosis of meningitis correlated with CSF analysis. ISRN Radiol 2014; 2014: 578986.
9
Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY. CNS complications of radiotherapy and chemotherapy. Lancet 2009; 374: 1639-51.
10
McTyre E, Scott J, Chinnaiyan P. Whole brain radiotherapy for brain metastasis. Surg Neurol Int 2013; 4: S236-44.
11
Cross NE, Glantz MJ. Neurologic complications of radiation therapy. Neurol Clin 2003; 21: 249-77.
12
Walker AJ, Ruzevick J, Malayeri AA, Rigamonti D, Lim M, Redmond KJ, et al. Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol 2014; 10: 1277-97.
13
Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 2008;26:2192-7.
14
Pande AR, Ando K, Ishikura R, Nagami Y, Ogawa M, Kamikonya N, et al. Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia. Radiat Med 2006; 24: 515-9.
